New heart scan could spot salvageable muscle after attack

NCT ID NCT07443696

Recruiting now Diagnosis Sponsor: Sinotau Pharmaceutical Group Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new PET imaging method that uses a special tracer called XTR003 along with FDG to see which parts of the heart are still alive in people with heart failure from blocked arteries. About 40 to 60 participants will be randomly assigned to receive either the new fasting imaging method or a standard glucose-loaded scan. The goal is to see if the new method better predicts which heart regions will improve after surgery to restore blood flow.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: XTR003 injection (a fatty-acid tracer for PET imaging)
What this could lead to: If successful, this imaging method could help doctors better identify which heart muscle is still alive and could recover after surgery.
What could go wrong: This is a small, early-phase study with only 40-60 participants. The new imaging method may not prove more accurate than existing tests, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cardiomyopathy heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEART FAILURE ISCHEMIC CARDIOMYOPATHY

Contacts and locations

Locations

Beijing Anzhen Hospital, Capital Medical University
RECRUITING

Beijing, Beijing Municipality, China
Beijing Chaoyang Hospital, Capital Medical University
NOT_YET_RECRUITING

Beijing, China
TEDA International Cardiovascular Hospital
NOT_YET_RECRUITING

Tianjin, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.